The hepatocyte growth factor receptor is encoded by the MET gene, which is expected to perform an influential function in the invasion, recurrence, migration, and drug resistance of glioma cells.26, 27Approximately 30% of glioblastoma patients are represented by overexpression of MET. This evidence concerns the gene MET and central nervous system cancer.